Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review
Rashidul Alam Mahumud, Khorshed Alam, Syed Afroz Keramat, et al.
PLoS ONE (2020) Vol. 15, Iss. 6, pp. e0233499-e0233499
Open Access | Times Cited: 25

Showing 25 citing articles:

Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18–26 years in China: a randomised blinded clinical trial
Fengcai Zhu, Guohua Zhong, Weijin Huang, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 11, pp. 1313-1322
Closed Access | Times Cited: 17
Burden of HPV-induced diseases and cost effectiveness of catch-up vaccination in Czech Republic: a model-based study
Vojtěch Kamenský, Lukáš Dostálek, Martin Rožánek, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Modelling epidemiological and economics processes – the case of cervical cancer
F Taeger, Lena Mende, Steffen Fleßa
Health Economics Review (2025) Vol. 15, Iss. 1
Open Access
Economic Burden of Cervical Cancer in Bulgaria
Hristina Lebanova, Svetoslav Stoev, Emilia Naseva, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 3, pp. 2746-2746
Open Access | Times Cited: 12
Associations of geographic-based socioeconomic factors and HPV vaccination among male and female children in five US states
Serena Xiong, Sarah Humble, Alan R. Barnette, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
Daniel Tobias Michaeli, Sophia Stoycheva, Simon Mashudu Marcus, et al.
Clinical Drug Investigation (2022) Vol. 42, Iss. 4, pp. 333-343
Open Access | Times Cited: 9
Uptake of human papilloma virus vaccine and intention to vaccinate among women in Saudi Arabia
Alaa Sami Barhamain, Osama Mohammed Alwafi
Medical Science (2022) Vol. 26, Iss. 123, pp. 1-1
Open Access | Times Cited: 8
Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore
Lee Cheng Phua, Cheuk‐Wai Choi, Joseph T. Wu, et al.
Vaccine (2021) Vol. 39, Iss. 16, pp. 2255-2263
Closed Access | Times Cited: 11
Cost-effectiveness of human papillomavirus vaccine in China: a systematic review of modelling studies
Wenchuan Shi, Xiaoli Cheng, Haitao Wang, et al.
BMJ Open (2021) Vol. 11, Iss. 12, pp. e052682-e052682
Open Access | Times Cited: 10
Increasing HPV vaccination coverage to prevent oropharyngeal cancer: A cost-effectiveness analysis
Sung Eun Choi, Abhishek Choudhary, Jingyi Huang, et al.
Tumour Virus Research (2021) Vol. 13, pp. 200234-200234
Open Access | Times Cited: 9
Population-Based Incidence of Guillain-Barré Syndrome During Mass Immunization With Viral Vaccines: A Pooled Analysis
Fengge Wang, Donglan Wang, Yingjie Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Recommended Interventions to Improve Human Papillomavirus Vaccination Uptake among Adolescents: A Review of Quality Improvement Methodologies
Karniza Khalid, Kun Yun Lee, Nur Farihan Mukhtar, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1390-1390
Open Access | Times Cited: 3
On the Elimination of Infections Related to Oncogenic Human Papillomavirus: An Approach Using a Computational Network Model
Cintia Muñoz-Quiles, Javier Díez‐Domingo, L. Acedo, et al.
Viruses (2021) Vol. 13, Iss. 5, pp. 906-906
Open Access | Times Cited: 7
Assessing the Health and Economic Outcomes of a 9-Valent HPV Vaccination Program in the United Kingdom
Kwame Owusu‐Edusei, Cody Palmer, Olga Ovcinnikova, et al.
Journal of health economics and outcomes research (2022) Vol. 9, Iss. 1, pp. 140-150
Open Access | Times Cited: 4
An Umbrella Review of the Cost Effectiveness of Human Papillomavirus Vaccines
Phuong T. Tran, Munaza Riaz, Ziyan Chen, et al.
Clinical Drug Investigation (2022) Vol. 42, Iss. 5, pp. 377-390
Closed Access | Times Cited: 3
Hospitalization burden associated with anus and penis neoplasm in Spain (2016-2020)
Víctor Fernández‐Alonso, Ruth Gil-Prieto, Maria Amado-Anton-Pacheco, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Forecasting Disease Burden with a Dynamic Transmission Model of Human Papillomavirus and Recurrent Respiratory Papillomatosis in the United States
Cody Palmer, Edith Morais, Joseph E. Tota
Viruses (2024) Vol. 16, Iss. 8, pp. 1283-1283
Open Access
Comparison and Prediction of Human Papillomavirus Vaccination Trends among Koreans and Foreigners
Juwon Lim
The Korean Journal of Aerospace and Environmental Medicine (2023) Vol. 33, Iss. 3, pp. 76-79
Open Access | Times Cited: 1
Assessing the Health and Economic Outcomes of a 9-Valent HPV Vaccination Program in the United Kingdom
Kwame Owusu‐Edusei, Cody Palmer, Olga Ovcinnikova, et al.
Journal of health economics and outcomes research (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Current Resources for Evidence-Based Practice, January 2021
Marit L. Bovbjerg, S Krishna Pillai, Melissa Cheyney
JOGN Nursing (2020) Vol. 50, Iss. 1, pp. 102-115
Open Access | Times Cited: 2
On the Elimination of Cancers Related to Oncogenic Human Papillomavirus: an Approach using a Computational Network Model
Cintia Muñoz-Quiles, Javier Díez‐Domingo, L. Acedo, et al.
(2021)
Open Access | Times Cited: 1
A targeted literature review of health economic analyses of human papillomavirus vaccination from various countries
Hannah A Segal, Nazia Rashid
International Journal of STD & AIDS (2023) Vol. 34, Iss. 8, pp. 512-517
Open Access
Vaccines and the Prevention of Dermatologic Diseases
Giancarlo Bessa
Springer eBooks (2023), pp. 1501-1520
Closed Access
Correction: Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review
Rashidul Alam Mahumud, Khorshed Alam, Syed Afroz, et al.
PLoS ONE (2023) Vol. 18, Iss. 11, pp. e0294379-e0294379
Open Access
Cost effectiveness of 9-valent HPV vaccine for cervical cancer prevention

PharmacoEconomics & Outcomes News (2020) Vol. 856, Iss. 1, pp. 10-10
Closed Access
Page 1

Scroll to top